The
information contained within this announcement is deemed by the
Company to constitute inside information as stipulated under the
Market Abuse Regulation (EU) No. 596/2014 as it forms part of
United Kingdom domestic law by virtue of the European Union
(Withdrawal) Act 2018, as amended by virtue of the Market Abuse
(Amendment) (EU Exit) Regulations 2019.
12 December
2024
Benchmark Holdings plc
("Benchmark" or the
"Company")
Chairman Appointment
The Company announces the appointment
of Tripp Lane as Chairman with effect from 17th
December 2024, following the General Meeting on 16th December to
approve the sale of the Genetics business as announced on 25
November 2024. Peter George will retire from the Board on Tripp's
appointment and will ensure an orderly handover.
Tripp Lane is a founding partner of
Delancey Cove LLC, an advisory firm focused on
transitional governance and management of both private
and public companies across all stages of their life
cycle.
Prior to founding Delancey Cove LLC, Tripp
invested in public and private debt and equity markets
at BlueMountain Capital LLC in London and at Apax
Partners in London and New York.
Tripp Lane,
incoming Chairman commented:
"I am delighted to join the Board of
Benchmark as Chairman, and I am excited to work with the management
team and the board on the next stage of the Company's
journey"
Peter George,
retiring Chairman, commented:
"It has been an honour and privilege to serve
both as Executive and Non-Executive Chair at Benchmark. Staff and
Management have been of the highest calibre which made it easier. I
have also served with many dedicated Non-Executive Directors over
the years, and I thank them for their support and the support of
our investors. I would like to pay particular thanks to Trond
Williksen, Septima Maguire and Susan Searle who have been
outstanding."
Trond
Williksen, CEO, commented
"On behalf of the Board and the Management team
at Benchmark I would like to thank Peter George for his outstanding
leadership through the past six years overseeing the transformation
of Benchmark starting with a comprehensive restructuring in 2020
through to an organisational change programme and the Strategic
Review this year resulting in value realisation for
shareholders."
"I welcome Tripp who is well placed to take the
Company through the next phase of value realisation for our
shareholders".
The following
information is disclosed in accordance with Rule 17 and paragraph
(g) of Schedule 2 of the AIM Rules for Companies in connection with
the appointment of Nathan "Tripp" Lane to the Board of the
Company:
Nathan 'Tripp' Lane (aged 47) has held the
following directorships and/or partnerships in the past five
years.
Current
Directorships
|
Past
Directorships (last five years)
|
Cell C Limited
|
Card Factory Plc
|
Delancey Cove, LLC
|
Cardfactory US Holdings Inc
|
LB NewHoldCo LLC
|
Cardfactory USA LLC
|
LBI ehf.
|
Intralot Inc
|
Maisons du Monde SA
|
Matrix Holdco LLC
|
Mavenir Private Holdings II Ltd
|
Novartex SAS
|
Mavenir Systems Inc
|
Retailnext Holdings Inc
|
National CineMedia Inc
|
Resegon Capital Partners LLP
|
PVA Company LLC
|
Resegon Topco Limited
|
Quoizel LLC
|
Turvo Inc
|
Slater and Gordon UK Holdings Limited
|
Vivarte SAS (a subsidiary of Novartex
SAS)
|
Stonepeak Falcon Holdings Inc
|
|
· Nathan served on
the board of Cengage Learning GP 1 LLC from 11 April
to 23 August 2013. Cengage Learning GP I LLC, the general
partner of Cengage Learning Holdings II, LP, filed for Chapter 11
reorganisation on 2 July 2013. Cengage, a global provider
of educational content, technology, and services, confirmed a
reorganisation plan on 14 March 2014, after settling with
certain creditors.
· Nathan was
appointed to the board of Matrix Holdco LLC, the controlling
entity of Mobileum, Inc., on 20 December
2023. Matrix Holdco LLC, a provider of analytics solutions for
telecom operators, filed for Chapter 11 reorganisation
on 23 July 2024. The company emerged from Chapter 11
on 12 September 2024, at which point Nathan resigned from
the board.
Nathan has no beneficial interest in the equity
securities of Benchmark Holdings plc.
There is no further information to be disclosed
in relation to Nathan Lane's appointment pursuant to AIM Rule 17 or
Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for
Companies.
Enquiries
For further information, please
contact:
|
|
Benchmark
Holdings plc
|
benchmark@mhpgroup.com
|
Trond Williksen, CEO
|
|
Septima Maguire, CFO
|
|
Ivonne Cantu, Investor Relations
|
|
|
|
|
|
Deutsche Numis
(Nominated Adviser and Broker)
|
Tel: 020 7260 1000
|
Freddie Barnfield, Duncan
Monteith, Sher Shah
|
|
|
|
MHP
|
Tel: : 07890 952
661
|
Katie Hunt, Reg Hoare, Samuel
Garner
|
benchmark@mhpgroup.com
|
|
|